Dr. Kean Sahin

Dr. Kenan Sahin is the Founder/President of CAMX Power. Dr. Sahin is also the Founder/President of TIAX LLC and serves as its Chief Technology Officer. CAMX Power was formerly a division of TIAX LLC and became a separate company in May 2014.

With its laboratories, scientists, engineers and technicians, and links to innovation sources, CAMX Power selects and matures early stage technologies primarily in energy, into innovative, de-risked, IP-based and market-ready products for service-supported licensing, sale or joint ventures.

CAMX Power is leading with its flagship product CAM-7®, one of the most advanced cathode materials for lithium-ion battery applications in the automotive and high-end portable electronics markets. In 2016, BASF and Johnson Matthey licensed CAM-7 for scaled-up production and sale into the electric vehicle markets.

In 2003, the World Economic Forum named Dr. Sahin one of its 40 Technology Pioneers. He received the New England Business and Technology's first "Circle of Excellence" award in 2004. In 2006, he was given the Golden Door Award by the International Institute of Boston in recognition of his achievements as both an entrepreneur and an academic. In 2007, TIAX was recognized as one of the Global Growth companies by the World Economic Forum, and Dr. Sahin was invited to Davos-East held in Dalian, China to address Innovation. In 2010, he was awarded the Ellis Island Medal of Honor and this recognition was entered into the US Congressional records.

Dr. Sahin's role at CAMX Power continues a multifaceted career as academic, technologist, entrepreneur, and philanthropist. He served on the faculties of MIT, Harvard, and the University of Massachusetts Amherst. He has global patents and numerous academic publications. He has been a frequent speaker on technology, innovation and implementation.

In 1982, Dr. Sahin founded Kenan Systems with a $1,000 personal investment to validate in industry some of his academic pursuits, in particular Expert Systems with Natural Language Processing (branches of AI) and large data processing with multidimensional languages for decision support. Using these technologies, Kenan Systems went on to develop major transaction systems for large companies, especially in telecommunications (Arbor/Kenan Billing and Customer Care Systems and numerous major decision support/analytics systems for marketing, budgeting and technology assessment) and for banking (CitiExpert for funds transfer automation and comprehensive decision support/analytics systems for HR, marketing and technology assessment). The company became a world leader in its pursuits creating nearly 1,000 professional jobs and expanding into many countries. Dr. Sahin was named the Ernst & Young New England Entrepreneur of the Year in 1998.

In 1999, Dr. Sahin sold Kenan Systems to Lucent Technologies/Bell Laboratories and Dr. Sahin became Vice President of Software Technology at Bell Labs, a member of the managing group of Bell Labs and then the President of Lucent’s Software Products Group, managing 4,500 people until he returned to Boston and founded TIAX LLC in 2002.

Dr. Sahin serves only on not-for-profit boards.  He is or has been on the Boards of MIT (life member), Argonne National Laboratories, Executive Committee of the Council on Competitiveness in Washington, DC., MIT Energy Initiative Advisory Board, NEMA in Washington, DC, Boston Symphony Overseers, Boston Museum Fine Arts Overseers, Boston Museum of Science, American Field Service (AFS) and Robert College of Istanbul.

In June 2015, Dr. Sahin was the commencement speaker at the graduation ceremonies of the Bosphorus University (Boğaziçi Üniversitesi) in Istanbul Turkey.  At the same ceremony he was awarded an Honorary Doctorate in Engineering.

He finished his BS as well as his PhD at MIT, winning multiple Ford Doctoral fellowships and being appointed to faculty as an instructor three years into his doctoral program, and then receiving the Salgo-Noren Excellence in Teaching Award. His doctoral thesis led to numerous international patents.